Universe Pharmaceuticals Ownership 2024 | Who Owns Universe Pharmaceuticals Now?

Overview RevenueFinancials Chart

Institutional Ownership

0.47%

Insider Ownership

8.80%

Retail Ownership

90.73%

Institutional Holders

4.00

Universe Pharmaceuticals Institutional Shareholders

Institutional Shareholders by % of Total Shares

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
ACADIAN ASSET MANAGEMENT LLC	-	-	-	-39,329	-100.00%	-	Sep 30, 2023
TWO SIGMA SECURITIES, LLC	-	-	-	-18,483	-100.00%	-	Sep 30, 2023
HRT FINANCIAL LP	-	-	-	-16,700	-100.00%	-	Sep 30, 2023

Universe Pharmaceuticals's largest institutional shareholder is ACADIAN ASSET MANAGEMENT LLC, holding 0.00% of the company's total share outstanding, currently valued at -. The top 10 institutional shareholders own together 0.00% of the company.

Institutional Shareholders by % of Total Assets

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
ACADIAN ASSET MANAGEMENT LLC	-	-	-	-39,329	-100.00%	-	Sep 30, 2023
TWO SIGMA SECURITIES, LLC	-	-	-	-18,483	-100.00%	-	Sep 30, 2023
HRT FINANCIAL LP	-	-	-	-16,700	-100.00%	-	Sep 30, 2023

The largest Universe Pharmaceuticals shareholder by % of total assets is ACADIAN ASSET MANAGEMENT LLC. The company owns 0.00 shares of Universe Pharmaceuticals (UPC), representing 0.00% of its total assets.

Institutional Buyers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
HRT FINANCIAL LP	-	-	-	-16,700	-100.00%	-	Sep 30, 2023
TWO SIGMA SECURITIES, LLC	-	-	-	-18,483	-100.00%	-	Sep 30, 2023
ACADIAN ASSET MANAGEMENT LLC	-	-	-	-39,329	-100.00%	-	Sep 30, 2023

As of Sep 30 2023, Universe Pharmaceuticals's largest institutional buyer is HRT FINANCIAL LP. The company purchased -16.70K stocks of UPC, valued at -.

Institutional Sellers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
ACADIAN ASSET MANAGEMENT LLC	-	-	-	-39,329	-100.00%	-	Sep 30, 2023
TWO SIGMA SECURITIES, LLC	-	-	-	-18,483	-100.00%	-	Sep 30, 2023
HRT FINANCIAL LP	-	-	-	-16,700	-100.00%	-	Sep 30, 2023

As of Sep 30 2023, Universe Pharmaceuticals's biggest institutional seller is ACADIAN ASSET MANAGEMENT LLC. The company sold -39.33K shares of UPC, valued at -.

Institutional New positions

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date

Institutional Sold Out

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
ACADIAN ASSET MANAGEMENT LLC	-	-	-	-39,329	-100.00%	-	Sep 30, 2023
TWO SIGMA SECURITIES, LLC	-	-	-	-18,483	-100.00%	-	Sep 30, 2023
HRT FINANCIAL LP	-	-	-	-16,700	-100.00%	-	Sep 30, 2023

Universe Pharmaceuticals's largest sold out institutional shareholder by shares sold is ACADIAN ASSET MANAGEMENT LLC, sold -39.33K shares, valued at -, as of undefined.

Universe Pharmaceuticals Institutional Ownership Trends

Institutional Holdings Trend

Date	Holdings	Change %
30 Jun, 23	4	100.00%
31 Mar, 23	2	-33.33%
31 Dec, 22	3	-
30 Sep, 22	3	-25.00%
30 Jun, 22	4	-
31 Mar, 22	4	-20.00%
31 Dec, 21	5	-
30 Sep, 21	5	150.00%
30 Jun, 21	2	-50.00%
31 Mar, 21	4	-

As of 30 Jun 23, 4 institutions are holding Universe Pharmaceuticals's shares, representing an increase of 100.00% compared to the previous quarter.

Shares Outstanding Trend

Date	Shares Outstanding	Change %
30 Jun, 23	98,532	37.71%
31 Mar, 23	71,549	8.82%
31 Dec, 22	65,749	48.68%
30 Sep, 22	44,223	-84.73%
30 Jun, 22	289,650	-73.84%
31 Mar, 22	1,107,394	-7.19%
31 Dec, 21	1,193,142	249.59%
30 Sep, 21	341,302	734.09%
30 Jun, 21	40,919	-50.64%
31 Mar, 21	82,906	-

Universe Pharmaceuticals (UPC) has 98.53K shares outstanding as of 30 Jun 23, up 37.71% compared to the previous quarter.

Institutional Ownership Trend

Date	Ownership %	Change %
30 Jun, 23	0.47%	404.20%
31 Mar, 23	0.34%	347.56%
31 Dec, 22	0.31%	757.45%
30 Sep, 22	0.20%	11.47%
30 Jun, 22	1.33%	3.91%
31 Mar, 22	5.83%	14.76%
31 Dec, 21	6.29%	194.42%
30 Sep, 21	1.80%	3868.69%
30 Jun, 21	0.22%	113.00%
31 Mar, 21	0.44%	-

As of 30 Jun 23, Universe Pharmaceuticals is held by 0.47% institutional shareholders, representing a 404.20% growth compared to 31 Mar 23.

Institutional Increased Positions Trend

Date	Increased Positions	Change %
30 Jun, 23	2	100.00%
31 Mar, 23	1	-
31 Dec, 22	1	-50.00%
30 Sep, 22	2	-
30 Jun, 22	2	-
31 Mar, 22	-	-100.00%
31 Dec, 21	5	25.00%
30 Sep, 21	4	300.00%
30 Jun, 21	1	-75.00%
31 Mar, 21	4	-

2 institutional shareholders have increased their position in UPC stock as of 30 Jun 23 compared to 1 in the previous quarter (a 100.00% increase).

Institutional Reduced Positions Trend

Date	Reduced Positions	Change %
30 Jun, 23	1	-
31 Mar, 23	-	-100.00%
31 Dec, 22	2	-
30 Sep, 22	-	-100.00%
30 Jun, 22	1	-66.67%
31 Mar, 22	3	-
31 Dec, 21	-	-
30 Sep, 21	-	-100.00%
30 Jun, 21	1	-
31 Mar, 21	-	-

1 institutional shareholders have reduced their position in UPC stock as of 30 Jun 23 compared to - in the previous quarter (a 0.00% increase).

All Institutional Ownership Trend Data

Date	Holdings	Change %	Shares Outstanding	Change %	Ownership %	Change %	Increased Positions	Change %	Reduced Positions	Change %
30 Jun, 23	4	100.00%	98,532	37.71%	0.47%	404.20%	2	100.00%	1	-
31 Mar, 23	2	-33.33%	71,549	8.82%	0.34%	347.56%	1	-	-	-100.00%
31 Dec, 22	3	-	65,749	48.68%	0.31%	757.45%	1	-50.00%	2	-
30 Sep, 22	3	-25.00%	44,223	-84.73%	0.20%	11.47%	2	-	-	-100.00%
30 Jun, 22	4	-	289,650	-73.84%	1.33%	3.91%	2	-	1	-66.67%
31 Mar, 22	4	-20.00%	1,107,394	-7.19%	5.83%	14.76%	-	-100.00%	3	-
31 Dec, 21	5	-	1,193,142	249.59%	6.29%	194.42%	5	25.00%	-	-
30 Sep, 21	5	150.00%	341,302	734.09%	1.80%	3868.69%	4	300.00%	-	-100.00%
30 Jun, 21	2	-50.00%	40,919	-50.64%	0.22%	113.00%	1	-75.00%	1	-
31 Mar, 21	4	-	82,906	-	0.44%	-	4	-	-	-

Universe Pharmaceuticals Insider Shareholders Trades

Open Market Insider Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source

Open Market Insider Buys

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source

Insider Sells

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Jun 30, 2004	POYNTER LOU ANN	director	-		Sell	-	-	-	181,862
May 04, 2004	WHITE JOHN V	officer	CEO,Union Planters Bank, Memph	D-Return	Sell	6,468	$27.75	$179.49K	73,325
May 04, 2004	WHITE JOHN V	officer	CEO,Union Planters Bank, Memph	F-InKind	Sell	766	$27.75	$21.26K	72,559
May 04, 2004	WHITE JOHN V	officer	CEO,Union Planters Bank, Memph	M-Exempt	Sell	9,364	$19.17	$179.48K	29,055

All Insider Owners Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Jun 30, 2004	HARTON LYNN	officer	-		Buy	-	-	-	-
Jun 30, 2004	HENRIQUES ADOLFO	officer	CEO,Union Planters Bank, FL		Buy	-	-	-	675
Jun 30, 2004	HENRIQUES ADOLFO	officer	CEO,Union Planters Bank, FL		Buy	-	-	-	338
Jun 30, 2004	MOORE JACKSON W	director, officer	Chairman and Chief Executive O		Buy	-	-	-	-
Jun 30, 2004	POYNTER LOU ANN	director	-		Sell	-	-	-	181,862
Jun 30, 2004	POYNTER LOU ANN	director	-		Buy	-	-	-	90,000
Jun 30, 2004	POYNTER LOU ANN	director	-		Buy	-	-	-	81,554
Jun 30, 2004	POYNTER LOU ANN	director	-		Buy	-	-	-	3,719
Jun 30, 2004	ROBERTS JOHN R	director			Buy	-	-	-	-
Jun 30, 2004	SCHENCK STEVE J	officer	-		Buy	-	-	-	-
Jun 30, 2004	WHITE JOHN V	officer	-		Buy	-	-	-	-
May 04, 2004	WHITE JOHN V	officer	CEO,Union Planters Bank, Memph	M-Exempt	Buy	9,364	$19.17	$179.48K	81,923
May 04, 2004	WHITE JOHN V	officer	CEO,Union Planters Bank, Memph	D-Return	Sell	6,468	$27.75	$179.49K	73,325
May 04, 2004	WHITE JOHN V	officer	CEO,Union Planters Bank, Memph	F-InKind	Sell	766	$27.75	$21.26K	72,559
May 04, 2004	WHITE JOHN V	officer	CEO,Union Planters Bank, Memph	M-Exempt	Sell	9,364	$19.17	$179.48K	29,055
May 04, 2004	WHITE JOHN V	officer	CEO,Union Planters Bank, Memph	A-Award	Buy	7,234	$27.75	$200.74K	7,234
Apr 23, 2004	HARTON LYNN	officer	Senior Executive V.P.	J-Other	Buy	126	-	-	126
Apr 22, 2004	HENRIQUES ADOLFO	officer	CEO,Union Planters Bank, FL	J-Other	Buy	28	-	-	671
Apr 22, 2004	HENRIQUES ADOLFO	officer	CEO,Union Planters Bank, FL	J-Other	Buy	295	-	-	524
Apr 22, 2004	MOORE JACKSON W	director, officer	Chairman and Chief Executive O	J-Other	Buy	305	$30.20	$9.22K	27,944

The last insider sell of Universe Pharmaceuticals's stock was made by POYNTER LOU ANN on Jun 30 2004, selling - shares at - per share (valued at -).

Universe Pharmaceuticals Insider Ownership Trends

All Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio

Open Market Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio

Universe Pharmaceuticals Peer Ownership

Ticker	Company
QLI	Qilian International Holding Group Limited
TKNO	Alpha Teknova, Inc.
PAHC	Phibro Animal Health Corporation
RGC	Regencell Bioscience Holdings Limited
SSIC	Silver Spike Investment Corp.
PROC	Procaps Group S.A.
IMCC	IM Cannabis Corp.
EGRX	Eagle Pharmaceuticals, Inc.

UPC Ownership FAQ

Who Owns Universe Pharmaceuticals?

Universe Pharmaceuticals is owned by institutional shareholders (0.47%), insiders (8.80%), and public (90.73%). The largest institutional shareholder of Universe Pharmaceuticals is ACADIAN ASSET MANAGEMENT LLC (0% of total shares) and the top mutual fund owner is (0% of total shares).

Who are the major institutional shareholders of Universe Pharmaceuticals?

Universe Pharmaceuticals's major institutional shareholders are ACADIAN ASSET MANAGEMENT LLC, TWO SIGMA SECURITIES, LLC, and HRT FINANCIAL LP. The top five shareholders own together 0% of the company's share outstanding.

How many Universe Pharmaceuticals shareholders are there?

As of Jun 2023, there are 4 institutional shareholders of Universe Pharmaceuticals.

What percentage of Universe Pharmaceuticals is owned by ACADIAN ASSET MANAGEMENT LLC?

ACADIAN ASSET MANAGEMENT LLC owns 0 shares of Universe Pharmaceuticals, representing 0% of the company's total shares outstanding, valued at $0 (as of Sep 2023).

What percentage of Universe Pharmaceuticals is owned by TWO SIGMA SECURITIES, LLC?

As of Sep 2023, TWO SIGMA SECURITIES, LLC holds 0 shares of Universe Pharmaceuticals (UPC), compromising 0% of the company, valued at $0.

What percentage of Universe Pharmaceuticals is owned by HRT FINANCIAL LP?

HRT FINANCIAL LP is the third largest holder of Universe Pharmaceuticals. The company owns 0 of the company's shares outstanding (worth $0).